Enlivex Therapeutics Ltd.
ENLV
$1.09
$0.1414.20%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 18.20M | 19.51M | 20.55M | 23.50M | 24.51M |
| Total Receivables | 759.00K | 1.12M | 1.34M | 1.42M | 1.40M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 530.00K | 689.00K | 746.00K | 884.00K | 979.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 6.00K | 6.00K | 6.00K | 198.00K | 228.00K |
| Total Current Assets | 19.50M | 21.32M | 22.65M | 25.99M | 27.11M |
|
|
|||||
| Total Current Assets | 19.50M | 21.32M | 22.65M | 25.99M | 27.11M |
| Net Property, Plant & Equipment | 1.08M | 923.00K | 1.07M | 1.15M | 1.77M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 359.00K | 351.00K | 319.00K | 541.00K | 915.00K |
| Total Assets | 20.94M | 22.60M | 24.04M | 27.69M | 29.80M |
|
|
|||||
| Total Accounts Payable | 375.00K | 542.00K | 533.00K | 811.00K | 92.00K |
| Total Accrued Expenses | 2.38M | 2.52M | 2.37M | 2.61M | 2.35M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 275.00K | 264.00K | 239.00K | 235.00K | 346.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 142.00K | -- |
| Total Other Current Liabilities | -- | -- | -- | 142.00K | -- |
| Total Current Liabilities | 3.03M | 3.33M | 3.14M | 3.80M | 2.79M |
|
|
|||||
| Total Current Liabilities | 3.03M | 3.33M | 3.14M | 3.80M | 2.79M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 426.00K | 216.00K | 264.00K | 299.00K | 419.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.46M | 3.54M | 3.41M | 4.10M | 3.21M |
|
|
|||||
| Common Stock & APIC | 151.01M | 150.38M | 150.09M | 149.60M | 147.42M |
| Retained Earnings | -134.63M | -132.43M | -130.56M | -127.11M | -121.93M |
| Treasury Stock & Other | 1.10M | 1.10M | 1.10M | 1.10M | 1.10M |
| Total Common Equity | 17.48M | 19.05M | 20.63M | 23.59M | 26.59M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 17.48M | 19.05M | 20.63M | 23.59M | 26.59M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 17.48M | 19.05M | 20.63M | 23.59M | 26.59M |
|
|
|||||